Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SINOPEC CORP
00386
5
KUNLUN ENERGY
00135
CN Stock MarketDetailed Quotes
Guilin Sanjin Pharmaceutical (002275)
- 14.24
- +0.07+0.49%
Not Open Apr 10 15:00 CST
8.37BMarket Cap16.00P/E (TTM)
14.40High14.12Low22.84KlotVolume14.23Open14.17Prev Close32.58MTurnover0.41%Turnover Ratio16.04P/E (Static)587.57MShares17.1852wk High2.68P/B7.96BFloat Cap12.9152wk Low15.59Limit Up559.04MShs Float32.14Historical High12.75Limit Down1.98%Range %3.91Historical Low0.55Dividend TTM14.27Avg Price10.37KlotAsk3.86%Div Yield TTM100Lot Size11.84KlotBid
Guilin Sanjin Pharmaceutical (002275) Income Statement
All
YOY
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -7.14%1.46B | -6.56%998.34M | -3.32%466.57M | 1.03%2.19B | -3.49%1.57B | -10.53%1.07B | -32.59%482.59M | 10.81%2.17B | 13.40%1.63B | 19.96%1.19B |
| Operating revenue | -7.14%1.46B | -6.56%998.34M | -3.32%466.57M | 1.03%2.19B | -3.49%1.57B | -10.53%1.07B | -32.59%482.59M | 10.81%2.17B | 13.40%1.63B | 19.96%1.19B |
| Other operating revenue | ---- | -19.44%1.97M | ---- | -51.74%1.76M | ---- | -63.85%2.44M | ---- | -30.63%3.66M | ---- | 107.05%6.75M |
| Total operating cost | -11.26%1.01B | -9.17%666.09M | -5.87%333.81M | -1.30%1.67B | -2.05%1.14B | -4.48%733.37M | -29.15%354.63M | 4.21%1.69B | 9.56%1.16B | 19.27%767.8M |
| Operating cost | -8.56%362.27M | -10.30%242.18M | -16.54%103.75M | -0.52%583.34M | -8.12%396.2M | -15.42%269.99M | -30.92%124.31M | 3.10%586.4M | 8.62%431.23M | 15.09%319.24M |
| Operating tax surcharges | -12.64%20.67M | -7.64%16.28M | 11.36%5.46M | -0.25%37.24M | -0.59%23.66M | -5.12%17.62M | -43.48%4.9M | 3.46%37.33M | -0.73%23.8M | 2.64%18.57M |
| Operating expense | -10.26%449.99M | 0.28%292.26M | -0.21%154.74M | 2.65%736.87M | 9.53%501.43M | 6.46%291.44M | -14.75%155.07M | 33.35%717.86M | 30.62%457.81M | 59.87%273.74M |
| Administration expense | -10.70%97.67M | -19.27%61.8M | -15.18%32.88M | -25.35%151.39M | -28.25%109.37M | -17.88%76.55M | -24.91%38.77M | -26.07%202.81M | -10.30%152.44M | -14.00%93.22M |
| Financial expense | -98.69%-9.32M | -476.31%-7.31M | 8.91%-1.36M | -11.28%-16.03M | 21.20%-4.69M | -30.46%-1.27M | -128.52%-1.5M | 2.27%-14.41M | -2.91%-5.95M | 89.65%-971.89K |
| -Interest expense (Financial expense) | -61.64%3.14M | -99.09%49.34K | 48.85%4.54M | -15.37%13.84M | -69.43%8.2M | -5.66%5.4M | -71.99%3.05M | -19.17%16.36M | 97.00%26.81M | -76.48%5.72M |
| -Interest Income (Financial expense) | -109.81%-14.15M | 4.46%-8.51M | -8.05%-5.93M | 4.00%-29.93M | 80.45%-6.74M | -13.83%-8.9M | -4.19%-5.49M | 19.86%-31.18M | -39.05%-34.48M | 77.34%-7.82M |
| Research and development | -20.72%91.05M | -22.97%60.88M | 15.90%38.35M | 9.64%173.29M | 9.04%114.85M | 23.49%79.03M | -54.78%33.09M | -27.17%158.06M | -17.31%105.33M | -17.96%64M |
| Credit Impairment Loss | -84.69%-9.55M | 24.52%-7.58M | 22.32%-10.5M | -101,826.09%-9.22M | 4.69%-5.17M | -78.06%-10.04M | -85.52%-13.52M | 99.77%-9.05K | -6,343.84%-5.42M | 23.50%-5.64M |
| Asset Impairment Loss | ---- | ---- | ---- | -67.81%-27.13M | 40.63%-3.07M | ---- | ---- | -189.21%-16.17M | -439.92%-5.17M | -96.37%55.19K |
| Other net revenue | -35.64%19.97M | -49.39%10.23M | -287.64%-2.81M | 236.69%116.88M | 186.90%31.02M | 169.65%20.21M | -3.01%-724.97K | -67.52%34.71M | -53.36%10.81M | 8.21%7.49M |
| Fair value change income | 236.80%5.34M | 452.87%4.17M | --421.99K | 289.67%4.65M | 289.40%1.58M | 186.69%753.54K | ---- | 631.94%1.19M | 8.58%-836.6K | 5.01%-869.26K |
| Invest income | 311.92%3.55M | 95.50%688.02K | 8.20%-355.7K | 124.37%4.47M | 147.18%862.81K | 167.50%351.93K | -565.53%-387.46K | 15.04%1.99M | 4.52%-1.83M | 64.01%-521.4K |
| -Including: Investment income associates | ---- | ---- | ---- | -71.73%-1.96M | ---- | ---- | ---- | -37,211.81%-1.14M | ---- | ---- |
| Asset deal income | -99.95%1.86K | -99.96%1.86K | -99.94%2.8K | 4,901.90%83.35M | 275.82%4.14M | 267.96%4.31M | 405.58%4.55M | -94.67%1.67M | -2,325.76%-2.35M | -333,029.09%-2.56M |
| Other revenue | -36.89%20.62M | -47.86%12.95M | -11.66%7.62M | 31.99%60.76M | 23.68%32.68M | 45.82%24.84M | 9.05%8.63M | -44.70%46.04M | 8.71%26.42M | 12.49%17.03M |
| Operating profit | 1.08%470.02M | -3.60%342.47M | 2.14%129.95M | 24.41%644.77M | -2.71%464.99M | -18.12%355.25M | -40.73%127.23M | 16.00%518.26M | 19.74%477.92M | 20.97%433.86M |
| Add:Non operating Income | 0.47%468.69K | 21.00%287.12K | 381.53%192.43K | 69.38%950.98K | -23.91%466.51K | -43.23%237.29K | -83.78%39.96K | -25.89%561.46K | -36.68%613.12K | -33.01%417.99K |
| Less:Non operating expense | 102.88%944.49K | 152.32%910.47K | 421.80%391.09K | 230.81%1.79M | -51.19%465.55K | 12.86%360.84K | -35.41%74.95K | -60.22%540.68K | -76.92%953.75K | 49.10%319.71K |
| Total profit | 0.98%469.54M | -3.74%341.85M | 2.01%129.76M | 24.24%643.93M | -2.64%464.99M | -18.16%355.13M | -40.78%127.19M | 16.16%518.28M | 20.61%477.58M | 20.85%433.96M |
| Less:Income tax cost | 3.95%84.32M | 1.60%55.02M | -8.23%24.94M | 26.21%122.4M | 0.53%81.11M | -0.48%54.16M | -40.36%27.18M | -16.86%96.99M | 12.70%80.68M | -3.10%54.42M |
| Net profit | 0.35%385.23M | -4.70%286.83M | 4.80%104.82M | 23.79%521.53M | -3.28%383.88M | -20.70%300.97M | -40.90%100.02M | 27.85%421.3M | 22.35%396.89M | 25.30%379.54M |
| Net profit from continuing operation | 0.35%385.23M | -4.70%286.83M | 4.80%104.82M | 23.79%521.53M | -3.28%383.88M | -20.70%300.97M | -40.90%100.02M | 27.85%421.3M | 22.35%396.89M | 25.30%379.54M |
| Net profit of parent company owners | 0.35%385.23M | -4.70%286.83M | 4.80%104.82M | 23.79%521.53M | -3.28%383.88M | -20.70%300.97M | -40.90%100.02M | 27.85%421.3M | 22.35%396.89M | 25.30%379.54M |
| Earning per share | ||||||||||
| Basic earning per share | 1.54%0.66 | -3.92%0.49 | 5.88%0.18 | 23.61%0.89 | -4.41%0.65 | -21.54%0.51 | -41.38%0.17 | 28.57%0.72 | 23.64%0.68 | 22.64%0.65 |
| Diluted earning per share | 1.54%0.66 | -3.92%0.49 | 5.88%0.18 | 23.61%0.89 | -4.41%0.65 | -21.54%0.51 | -41.38%0.17 | 28.57%0.72 | 23.64%0.68 | 22.64%0.65 |
| Other composite income | 517.19%55.61M | 429.75%39.06M | 296.16%18.19M | 77.18%-8.41M | 47.40%-13.33M | -27.42%-11.84M | -377.78%-9.27M | -260.78%-36.85M | -294.63%-25.34M | -253.84%-9.3M |
| Other composite income of parent company owners | 517.19%55.61M | 429.75%39.06M | 296.16%18.19M | 77.18%-8.41M | 47.40%-13.33M | -27.42%-11.84M | -377.78%-9.27M | -260.78%-36.85M | -294.63%-25.34M | -253.84%-9.3M |
| Total composite income | 18.97%440.84M | 12.71%325.88M | 35.54%123M | 33.47%513.13M | -0.27%370.55M | -21.91%289.13M | -45.75%90.75M | 9.08%384.45M | 10.12%371.55M | 19.84%370.25M |
| Total composite income of parent company owners | 18.97%440.84M | 12.71%325.88M | 35.54%123M | 33.47%513.13M | -0.27%370.55M | -21.91%289.13M | -45.75%90.75M | 9.08%384.45M | 10.12%371.55M | 19.84%370.25M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Market Insights
Hot Topics Hot Topics
Middle East conflict spreads to the stock market! How should investors respond?
On April 12 local time, U.S. Vice President Vance stated that negotiations between the United States and Iran failed to reach an agreement,
牛牛課堂
Mar 4 17:09
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
牛牛課堂
Mar 18 18:18
Hormuz, Term Structure and USO: Navigating the Energy Storm